Investor Alert – Cytori Therapeutics
Are you concerned about your investment in Cytori Therapeutics? If so, the securities attorneys at The White Law Group may be able to help you by filing a FINRA Arbitration claim against the brokerage firm that sold you the investment.
Cytori Therapeutics, Inc. is a pharmaceutical company based in San Diego. The company develops and manufactures medical devices that enable the therapeutic use of the adult stem and regenerative cells naturally found within adipose (fat) tissue, according to reports.
According to SEC filings, the company reports 2018 net loss was $4.4 million, or $0.07 per share. Operating cash burn for Q1 was approximately $4.1 million.
Cytori shares reportedly dropped 60%.
Free Consultation with a Securities Attorney
The White Law Group is investigating the liability that FINRA registered brokerage firms may have for improperly recommending Cytori Therapeutics to investors.
Broker dealers are required to perform adequate due diligence on any investment they recommend and to ensure that all recommendations are suitable for the investor. Firms that fail to do so, may be held responsible for any losses in a FINRA arbitration claim.
FINRA can help resolve problems and disputes through two non-judicial proceedings: arbitration and mediation. FINRA’s Dispute Resolution forum handles nearly all of the securities-related arbitrations and mediations in the United States.
If you have concerns regarding your investment in Cytori Therapeutics and would like to speak with a securities attorney about your options, please call The White Law Group at 888-637-5510.
The White Law Group, LLC is a national securities fraud, securities arbitration, investor protection, and securities regulation/compliance law firm with offices in Chicago, Illinois and Franklin, Tennessee.
For more information on The White Law Group and its representation of investors in FINRA arbitration claims, visithttps://whitesecuritieslaw.com.
Tags: Cytori Therapeutics, Cytori Therapeutics default, Cytori Therapeutics help, Cytori Therapeutics high commissions, Cytori Therapeutics information, Cytori Therapeutics investigation, Cytori Therapeutics investment, Cytori Therapeutics investment losses, Cytori Therapeutics investor relations, Cytori Therapeutics investors, Cytori Therapeutics losses, Cytori Therapeutics ppm, Cytori Therapeutics private placement, Cytori Therapeutics prospectus, Cytori Therapeutics recovery options, Cytori Therapeutics risk, Cytori Therapeutics stock information, Cytori Therapeutics update, ytori Therapeutics complaints Last modified: May 22, 2018